Anavex Life Sciences Corp (AVXL)

[TTTav66]

Interesting post from another board:

I wonder if meeting the requirements of BRAIN, "$1.6 billion Brain Research through Advancing Innovative Neurotechnologies (BRAIN) initiative and the funding of the EUREKA prize competition to spur innovation in AD research.", is a slowdown? I'm no scientist, but I still wonder about 2-73 used as adjunctive therapy with another drug that clears the plaques. This would require combining of resources and "big data". Haven't said it in a while but GO SCIENTIST GO!

Makes me think about what is always mentioned when discussing master protocols: "they require "intensive" pretrial planning and coordination across a large number of stakeholders."

http://www.raps.org/Regulatory-Focus/News/2017/07/07/28050/FDA-Officials-Master-Protocols-Needed-for-Precision-Medicine/